Las Vegas, USA, July 27, 2022 (GLOBE NEWSWIRE) -- Neurovascular Embolization Devices Market is Expected to Reach Approximately USD 6.8 Billion by 2027, Asserts DelveInsight
The rise in the demand for Neurovascular Embolization Devices is predominantly attributed to the increasing prevalence of haemorrhages and the abnormalities in blood vessels present in the brain, increasing brain aneurysms and arteriovenous malformations (AVMs) due to sedentary lifestyles.
DelveInsight's Neurovascular Embolization Devices Market Insights and Forecast report provides the current and forecast Neurovascular Embolization Devices, upcoming innovations in the devices, individual market shares of the devices, challenges, drivers, and barriers, market trends, and key competitors in the Neurovascular Embolization Devices Market scenario.
Some of the salient features of the Neurovascular Embolization Devices Market report:
- According to DelveInsight analysis, North America is expected to dominate the overall Neurovascular Embolization Devices Market during the forecasted period.
- Key Neurovascular Embolization Devices companies proactively working in the market include Medtronic, Stryker, MicroVention, Inc. (Terumo Corporation), Johnson & Johnson Services, Inc., Penumbra, Inc., Balt, B. Braun Melsungen AG, Acandis GmbH, Wallaby Medical., Shape Memory Medical Inc., Zylox-Tonbridge Medical Technology Co., Ltd., Spartan Micro, Inc., KANEKA CORPORATION, Lepu Medical Technology(Beijing)Co., Ltd., Meril Life Sciences Pvt. Ltd., Boston Scientific Corporation, phenox GmbH, Merit Medical Systems., Perflow Medical Ltd., MicroPort Scientific Corporation., Cerus Endovascular, Rapid Medical, among others.
- As per DelveInsight estimates, the global Neurovascular Embolization Devices market was valued at USD 1.29 Billion in 2021, growing at a CAGR of 3.50% during the forecast period from 2022 to 2027, to reach USD 1.59 Billion by 2027.
- in July 2021, Zylox-Tonbridge Medical Technology Co., Ltd., a neuro- and peripheral-vascular interventional medical device company, raised USD 329 million to support the development and commercialization of its core products which include Neurovascular Embolization coils, a microcatheter for coiling, among others.
- In October 2020, Shanghai MicroPort NeuroTech Co., Ltd. (“MicroPort® NeuroTech”) received the registration certificates issued by China’s National Medical Products Administration (NMPA) for its proprietary NUMEN Coil Embolization System and NUMEN FR Coil Detachment System for the treatment of cerebral aneurysms through minimally invasive neurovascular intervention.
- In April 2020, Cerus Endovascular received CE Mark approval for its Neqstent Coil Assisted Flow Diverter device designed to treat intracranial aneurysms.
- In May 2019, Rapid Medical, a company focused on developing next-generation neurovascular devices, received FDA clearance for the Comaneci device as a temporary coil embolization assist device.
- Woven EndoBridge (WEB) Aneurysm Embolization System, an Intrasaccular Flow Disruption Device developed by Terumo Corporation, was approved by the US FDA in the year 2019.
- On September 17, 2019, Wallaby Medical received CE Mark approval and FDA 510(k) clearance for its differentiated embolic coil system, the Avenir Coil System intended to use for endovascular embolization of intracranial aneurysms and other neurovascular abnormalities.
Neurovascular Embolization Devices Overview
A Neurovascular Embolization Devices is an intravascular implant intended to permanently occlude blood flow to cerebral aneurysms and cerebral arteriovenous malformations.
Neurovascular Embolization Devices Market Insight
Geographically, the Global Neurovascular Embolization Devices market is studied for North America, Europe, Asia-Pacific, and the Rest of the World. Regarding revenue share, North America is expected to occupy a major share in the overall Neurovascular Embolization Devices market and is expected to hold its position during the forecasted period. This domination is due to the factors such as the increasing prevalence of the target population in the region. Moreover, the presence of key market players and the recent launch of embolization products in the region is anticipated to propel the Neurovascular Embolization market.
In addition, increasing government initiatives and funding to support research for brain aneurysms in the country would also increase the regional market for Neurovascular Embolization Devices. Moreover, strategic business activities and approval of regional products would also boost the regional market for Neurovascular Embolization Devices. For instance, in the year 2020, Kaneka Corporation received FDA approval for its new brain aneurysm embolization coil, i-ED COIL™.
Hence, the interplay of all the aforementioned factors will bolster the demand for the Neurovascular Embolization market in the region during the forecasted period.
Learn more about the Key companies covered in the report by downloading @ Neurovascular Embolization Devices Market Assessment
Neurovascular Embolization Devices Market Dynamics
The major factors driving the demand for Neurovascular Embolization Devices are the rising cases of haemorrhage stroke, brain aneurysm, and cerebral arteriovenous malformations due to sedentary lifestyles such as excessive consumption of alcohol, serious head injuries, and others. In addition, the rising prevalence of high blood pressure, growing product approval, and increase in the ageing population are also expected to boost the Neurovascular Embolization Devices market. In addition, approval of embolization products would also contribute to Neurovascular Embolization Devices market growth. Furthermore, the ongoing expansion of the geriatric population would also contribute to the Neurovascular Embolization Devices market in the forthcoming years.
However, certain complications associated with the neurovascular embolization procedures, such as procedural aneurysmal perforations by the microcatheter, micro-guidewire, or coil, among others, are likely to impede the Neurovascular Embolization Devices market. The unprecedented COVID-19 pandemic has slowed down the Neurovascular Embolization Devices market. This is owing to implementing lockdown, social distancing norms, and containment measures in several countries. Moreover, a halt in surgeries, decreased volumes in subarachnoid haemorrhage (SAH) hospitalizations, and ruptured aneurysm coiling interventions to prevent the transmission of the virus, among others, also affected the Neurovascular Embolization Devices market.
To gain a better understanding of the COVID-19 impact on the Neurovascular Embolization Devices industry, get a snapshot of the Neurovascular Embolization Devices Market Impact by COVID-19
Scope of the Neurovascular Embolization Devices Market Report
- Coverage: Global
- Study Period: 2019-2027
- Neurovascular Embolization Devices Market Segmentation By Product Type: Embolization Coils, Neurovascular Coil Assist Devices [Coil Assist Stents And Coil Assist Balloons], Liquid Embolization Systems, Flow Diversion Stents, Intrasaccular Flow Disruptor, Others
- Neurovascular Embolization Devices Market Segmentation By End-User: Hospitals, Ambulatory Surgical Centers
- Neurovascular Embolization Devices Market Segmentation By Geography: North America, Europe, Asia-Pacific, Rest of the World (Middle East, Africa, and South America)
- Key Neurovascular Embolization Devices Companies: Medtronic, Stryker, MicroVention, Inc. (Terumo Corporation), Johnson & Johnson Services, Inc., Penumbra, Inc., Balt, B. Braun Melsungen AG, Acandis GmbH, Wallaby Medical., Shape Memory Medical Inc., Zylox-Tonbridge Medical Technology Co., Ltd., Spartan Micro, Inc., KANEKA CORPORATION, Lepu Medical Technology(Beijing)Co., Ltd., Meril Life Sciences Pvt. Ltd., Boston Scientific Corporation, phenox GmbH, Merit Medical Systems., Perflow Medical Ltd., MicroPort Scientific Corporation., Cerus Endovascular, Rapid Medical, among others.
- Porter’s Five Forces Analysis, Product Profiles, Case Studies, KOL's Views, Analyst's View
Delveinsight Analysis: The Global Neurovascular Embolization Devices Market was valued at USD 1.29 billion in 2021, growing at a CAGR of 3.50% during the forecast period from 2022 to 2027, to reach USD 1.59 billion by 2027.
Know more about which MedTech player is set to dominate the Neurovascular Embolization Devices market @ Key Neurovascular Embolization Devices Companies
Table of Contents
| 1 | Report Introduction |
| 2 | Executive summary |
| 3 | Regulatory and Patent Analysis |
| 4 | Neurovascular Embolization Devices Market Key Factors Analysis |
| 5 | Neurovascular Embolization Devices Market Porter’s Five Forces Analysis |
| 6 | COVID-19 Impact Analysis on Neurovascular Embolization Devices Market |
| 7 | Neurovascular Embolization Devices Market Layout |
| 8 | Neurovascular Embolization Devices Market Global Company Share Analysis – Key 3-5 Companies |
| 9 | Neurovascular Embolization Devices Company and Product Profiles |
| 10 | Project Approach |
| 11 | KOL Views |
| 12 | DelveInsight Capabilities |
| 13 | Disclaimer |
| 14 | About DelveInsight |
Gain rich insights about the latest Neurovascular Embolization Devices regulatory approvals @ Neurovascular Embolization Devices Regulatory Landscape And Patent Analysis
Related Reports
Vascular Grafts Pipeline Insight and Competitive Landscape, 2022 report provides comprehensive insights about the pipeline landscape. It covers the pipeline drug profiles, including clinical and non-clinical stage products, and the vascular grafts companies, including RegenaGraft, Humacyte Inc, Innovia LLC, LeMaitre Vascular Inc, among others.
Vascular Access Devices Market
Vascular Access Devices Market Insight, Competitive Landscape, and Market Forecast, 2027 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key vascular access devices companies, including Cook Medical Inc., Becton, Dickinson, and Company, Teleflex Incorporated, among others.
Peripheral Vascular Interventions Market
Peripheral Vascular Interventions Market Insight, Epidemiology, and Market Forecast, 2032 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key Peripheral Vascular Interventions companies.
Peripheral Vascular Clot Management Interventions Market
Peripheral Vascular Clot Management Interventions Market Insight, Competitive Landscape, and Market Forecast, 2027 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key Peripheral Vascular Clot Management Interventions companies such as Boston Scientific Corporation, Penumbra Inc, Medtronic, Koninklijke Philips N.V., Edward LifeSciences Corporation, among others.
"DelveInsight’s ‘Surgical Microscopes Market Insight, Competitive Landscape and Market Forecast, 2027’ report delivers an in-depth understanding of Surgical Microscopes and the historical and forecasted Surgical Microscopes market trends, market drivers, market barriers, and key companies involved such as Novartis Ag, Danaher Corporation, Topcon Corporation, Carl Zeiss AG, Hagg-Streit Surgical GMBH, Accu-Scope Inc, Alltion (Wuzhou) Co., Ltd., Arri Medical, Karl Kaps GmbH & Co. Kg, Takagi Seiko Co. Ltd, and many others.
DelveInsight’s ‘Brain PET-MRI Systems Market Insight, Competitive Landscape and Market Forecast, 2027’ report delivers an in-depth understanding of Brain PET-MRI Systems and the historical and forecasted Brain PET-MRI Systems market trends, market drivers, market barriers and key companies involved such as Siemens Healthineers AG, Koninklijke Philips N.V., GE Healthcare, Bruker, Mediso Ltd., MR Solutions, Cubresa Inc., Aspect Imaging, and many others.
DelveInsight’s ‘Computed Tomography Market Insight, Competitive Landscape and Market Forecast, 2027’ report delivers an in-depth understanding of Computed Tomography and the historical and forecasted Computed Tomography market trends, market drivers, market barriers and key companies involved such as GE Healthcare, Siemens Healthcare Private Limited, Toshiba Corporation, Canon Medical Systems Corporation, FUJIFILM Holdings Corporation, Hitachi, Ltd, Shimadzu Corporation, PerkinElmer Inc, NeuroLogica Corp, and others.
DelveInsight’s ‘Ultrasound Devices Market Insight, Competitive Landscape and Market Forecast, 2027’ report delivers an in-depth understanding of Ultrasound Devices and the historical and forecasted Ultrasound Devices market trends, market drivers, market barriers and key companies involved such as FUKUDA DENSHI, Analogic Corporation, Hitachi, Ltd, Siemens Healthcare Private Limited, Toshiba Corporation, FUJIFILM Holdings Corporation, Canon Medical Systems Corporation, GE Healthcare, Sonacare Medical, and many others.
Transcatheter Heart Valve Replacement Devices Market
DelveInsight’s ‘Transcatheter Heart Valve Replacement Devices (THVR) Market Insights, Competitive Landscape and Market Forecast-2027’ report delivers an in-depth understanding of THVR and the historical and forecasted THVR market trends, market drivers, market barriers and key companies involved such as Edwards Lifesciences, Medtronic, Livanova plc, Abbott, Boston Scientific Corporation, CryoLife Inc, and others.
Congestive Heart Failure Treatment Devices Market
DelveInsight’s ‘Congestive Heart Failure Treatment Devices -Market Insights, Competitive Landscape and Market Forecast-2027’ report delivers an in-depth understanding of congestive heart failure treatment devices and the historical and forecasted congestive heart failure treatment devices market trends, market drivers, market barriers and key companies involved such as Abiomed, Medtronic, Abbott, Berlin Heart GmbH, Boston Scientific Corporation, HeartWare International, LivaNova PLC, and others.
DelveInsight’s ‘Deep Vein Thrombosis Market Insights, Competitive Landscape and Market Forecast-2027’ report delivers an in-depth understanding and the historical and forecasted DVT market trends, market drivers, market barriers and key companies like Cardinal Health, BioTab Healthcare, Devon Medical Products, DJO LLC, Arjo, HealthyStep, Boston Scientific Corporation, Control Medical Technology, Cook Medical, medi, Zimmer Biomet, Encompass Group, LLC, and many others.
The Global Sinus Dilation Devices Market report delivers in-depth understanding and the historical and forecasted market trends, market drivers, market barriers and key companies like Johnson & Johnson, Stryker, Dalent Medical, Intersect ENT, Inc., Smith & Nephew, Medtronic, Meril Life Sciences Pvt. Ltd., Olympus, Jilin Coronado Medical Apparatus Co., Leno Medical Technology (Shanghai) Co., SPIGGLE & THEIS Medizintechnik GmbH, and others.
Interested to know more about the breakthrough happenings? Take a look at the posts below
- Cardiac Monitoring Devices Market is Booming
- Ways IoT Has Transformed The Pulse Of Healthcare
- Boston Scientific starts recruitment for the EkoSonic™ Endovascular System
About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
For more insights, visit Pharma, Healthcare, and Biotech News
